Own your ow legal marijuana business
Your guide to making money in the multi-billion dollar marijuana industry
Carl Olsen's Marijuana Archive

Table 1

Age

N

%

10-19

15

8.9

20-29

28

16.6

30-39

31

18.3

40-49

24

14.2

50-59

34

20.1

60-69

22

13.0

70+

15

8.9

 

169

100.0

 

Sex

N

%

Male

76

45.0

Female

93

55.0

 

THC Group

N

%

Oral

94

55.6

Inhaled

75

44.4

 

Marijuana

N

%

Prior Use

69

41.1

No Prior Use

99

58.9

 

Tumor Stage

N

%

Local

16

9.4

Regional

28

16.6

Metastatic

125

74.0

 

Tumor Site

N

%

Breast

30

17.8

Ovary

30

17.8

Lung

17

10.1

Gastrointestinal

11

6.5

Genitourinary

27

15.9

Leukemia/Lymphoma

37

21.9

Other

17

10.0

 

Chemotherapy

N

%

Mild

20

11.8

Moderate

73

43.2

Severe

73

43.2

Not Reported

3

1.8

 

Group x Chemotherapy

N

%

Age
Mean

Age
Range

Oral-mild

8

4.8

45.8

19-64

Oral-moderate

42

25.3

48.3

13-78

Oral-severe

44

26.5

42.9

12-76

Inhaled-mild

12

7.2

54.7

35-76

Inhaled-moderate

31

18.7

42.2

17-73

Inhaled-severe

29

17.5

35.7

16-73

Table 1.  Frequencies and descriptive statistics of selected variables.

 

TABLE 2

 

N

SEX

AGE

AGE x SEX

   

M

F

 

M

F

Oral

94

39

55

45.6 yrs

39.1

50.2

Inhaled

75

37

38

41.9 yrs

37.2

46.9

 

 

CHEMOTHERAPY SEVERITY

PRIOR USE

 

Mild

Moderate

Severe

No

Yes

Oral

8

42

44

68

26

Inhaled

12

31

29

31

43

 

 

CANCER STAGE

 

Local

Regional

Metastatic

Oral

11

11

72

Inhaled

5

17

53

Table 2.  Oral versus inhaled groups: descriptive variable comparison

 

TABLE 3

 

NAUSEA

VOMITING

TIME

Mean

(SD)

Mean

(SD)
0  Baseline

4.53

(0.73)

4.26

(1.04)
1  Pre-THC

2.26

(1.39)

1.67

(1.27)
2  Post-THC

2.03

(1.22)

1.73

(1.24)
Time 1 - Time 0

-2.25

(1.52)

-2.56

(1.58)
Time 2 - Time 0

-2.50

(1.32)

-2.52

(1.46)
         
(Time 2 - Time 0) vs Group

     

Oral

-2.46

 

-2.40

 

Inhaled

-2.54

 

-2.69

 
         
(Time 2 - Time 0) vs Chemotherapy Severity

 

Mild

-2.76

 

-2.59

 

Moderate

-2.77

 

-2.84

 

Severe

-2.14

 

-2.19

 
         
(Time 2 - Time 0) vs Prior Use

   

Prior Use

-2.39

 

-2.42

 

No Prior Use

-2.56

 

-2.60

 
         
(Time 2 - Time 0) vs Randomization

   

Randomized

-2.57

 

-2.55

 

Non-Randomized

-2.47

 

-2.51

 

Table 3.  Means and standard deviations of pertinent variables.

 

TABLE 4

   

EUPHORIA

 

SLEEPY

 

AGITATION

Time  

No

Yes

?

 

No

Yes

?

 

No

Yes

?

 0  

142

4

2

 

59

28

61

 

124

21

3

 1  

78

67

3

 

38

52

58

 

131

14

3

 2  

81

64

3

 

27

68

53

 

126

19

3

 3  

98

47

3

 

40

54

54

 

136

9

3

 4  

94

27

27

 

34

42

72

 

115

5

28

                         
   

DEPRESSION

 

FEARFUL

 

ANXIOUS

Time  

No

Yes

?

 

No

Yes

?

 

No

Yes

?

 0  

122

24

2

 

123

22

3

 

80

65

3

 1  

141

4

3

 

136

9

3

 

115

30

3

 2  

136

9

3

 

139

6

3

 

118

26

4

 3  

140

5

3

 

139

5

4

 

128

16

4

 4  

113

3

29

 

115

4

29

 

106

13

29

Table 4.  Side effect frequencies derived from patients responding to at least four of the five times assessed.  Time 0 = Pre-THC; 1-4 is one to four hours post-THC.

Return to Report

Bryan A. Krumm
New Mexicans for Compassionate Use
phone (505) 286-1325
email
krummb@unm.edu
internet
http://www.livelinks.com/nmcu/
P.O.Box 4241
Albuquerque, N.M. 87196-4241

Library Highlights

Drug Information Articles

Drug Rehab